Study points to possible treatment for lethal pediatric brain cancer
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death.
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death.
SOURCE: NIH News Releases – Read entire story here.